Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Phospholipids, particularly phosphatidylcholine and phosphatidylserine, have been studied for their potential effects on lipid metabolism, including triglyceride levels. Scientific evidence supporting the use of phospholipids for lowering high triglycerides is modest but present. Some animal studies and limited human clinical trials suggest that phospholipids can influence lipid metabolism, partly by improving the transport and breakdown of triglycerides in the liver. For example, several studies have shown that supplementation with soy-derived phosphatidylcholine may modestly reduce serum triglyceride levels, likely by enhancing very-low-density lipoprotein (VLDL) secretion and improving hepatic lipid handling. However, the effects are generally mild and not consistently observed across all studies. The evidence base is much stronger for other interventions (such as omega-3 fatty acids) for high triglycerides, and phospholipids are not considered a first-line treatment.

Overall, while there is some scientific rationale and preliminary evidence for the use of certain phospholipids in managing high triglycerides, the quality and quantity of evidence are limited. Most guidelines do not recommend phospholipids as a primary therapy for hypertriglyceridemia. More robust, large-scale clinical trials are needed to confirm efficacy and establish appropriate dosing before phospholipids can be widely recommended for this indication.

More about Phospholipids (unspecified)
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by Phospholipids (unspecified)

Products containing Phospholipids (unspecified)